Nuwellis (NUWE) Cash from Investing Activities Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.36% |
| Dec 31, 2025 | 17.08% |
| Sep 30, 2025 | 6.62% |
| Jun 30, 2025 | 40.13% |
| Dec 31, 2024 | 2.42% |
| Sep 30, 2024 | 15.46% |
| Jun 30, 2024 | 27.15% |
| Mar 31, 2024 | 6.69% |
| Dec 31, 2023 | 30.01% |
| Sep 30, 2023 | -16.66% |
| Jun 30, 2023 | 58.54% |
| Mar 31, 2023 | -11.45% |
| Dec 31, 2022 | 209.03% |
| Sep 30, 2022 | 34.75% |
| Jun 30, 2022 | 11.27% |
| Dec 31, 2021 | -366.88% |
| Sep 30, 2021 | 57.90% |
| Jun 30, 2021 | -30.99% |
| Mar 31, 2021 | -47.58% |
| Dec 31, 2020 | -20.11% |
| Sep 30, 2020 | -11.52% |
| Jun 30, 2020 | -17.72% |
| Mar 31, 2020 | 25.08% |
| Dec 31, 2019 | 29.19% |
| Sep 30, 2019 | -27.17% |
| Jun 30, 2019 | -11.79% |
| Mar 31, 2019 | 2.28% |
| Dec 31, 2018 | 36.96% |
| Sep 30, 2018 | 2.94% |
| Jun 30, 2018 | -51.57% |
| Mar 31, 2018 | -44.65% |
| Dec 31, 2017 | -15.31% |
| Sep 30, 2017 | -49.39% |
| Jun 30, 2017 | -2.13% |
| Dec 31, 2016 | 55.84% |
| Sep 30, 2016 | -240.16% |
| Jun 30, 2016 | 10.22% |
| Mar 31, 2016 | -2.71% |